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Abstract
In Arizona during 1997–2013, coccidioidomycosis increased from 21 to 90 cases/100,000 
population, but coccidioidomycosis-associated deaths remained stable at 3–6 deaths/million 
population. We used the capture-recapture method by using death certificates and hospital 
discharge data to more fully estimate the total number of coccidioidomycosis-attributable deaths 
and compared this with published estimates. Death certificates were included if any cause of death 
included coccidioidomycosis; hospital discharge data deaths were included if any discharge 
diagnosis included coccidioidomycosis and laboratory confirmation. Among deaths during 2008–
2013, we identified 529 coccidioidomycosis-attributable deaths from death certificates and 560 
from hospital discharge data, with 251 deaths identified in both databases. Capture-recapture 
estimated 1,178 total coccidioidomycosis-attributable deaths, compared with 164 deaths 
(underlying cause of death) or 529 deaths (any cause of death) on death certificates. 
Coccidioidomycosis-attributable deaths are underreported from two- to sevenfold on Arizona 
death certificates, demonstrating an education need for death certifiers to document 
coccidioidomycosis mortality.
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Introduction
Coccidioidomycosis, or Valley fever, is a fungal respiratory disease caused by inhalation of 
Coccidioides species spores, which are found predominantly in the soil of arid environments 
in the southwestern United States and Central and South America.1 An estimated 150,000 
annual infections occur in the United States2 and ~40% of these are thought to be 
symptomatic.1 Of the ~147,000 coccidioidomycosis cases reported to the Centers for 
Disease Control and Prevention (CDC) during 1998–2014, approximately two-thirds 
occurred among Arizona residents.3 In 2007 in Arizona, 1,735 hospital visits associated with 
coccidioidomycosis with an estimated cost of $86 million were reported.4
In Arizona, despite a >fourfold increase in incidence of reported coccidioidomycosis during 
1997–2013 (from 21 cases/100,000 population to 90 cases/100,000 population),5 the death 
rate associated with coccidioidomycosis, calculated by using the death certificate underlying 
cause of death, had limited change during this period (range 3–6 deaths/million population).
6
 Similarly, a study estimating the coccidioidomycosis death rate by using underlying and 
secondary causes of death on death certificates reported a stable death rate in the United 
States of 0.59 deaths/million population during 1998–2008.7 Because of this discrepancy 
between reported cases and attributable deaths and the documented inaccuracies of cause of 
death data from death certificates,8–11 we used a capture-recapture method to more 
accurately estimate total number of deaths attributable to coccidioidomycosis and to 
calculate the sensitivity of death certificate data in capturing these deaths. We also conducted 
a case-control study to identify risk factors for omission of coccidioidomycosis as cause of 
death on the death certificate when it in fact contributed to death.
Methods
Data sources and case definitions
We used three databases to examine coccidioidomycosis cases and deaths as follows: the 
Arizona electronic death registry system (EDRS), the Arizona hospital discharge database 
(HDD), and Arizona’s statewide medical electronic disease surveillance intelligence system 
(MEDSIS).
EDRS captures data from death certificates, including demographics and causes of death. In 
Arizona, a medical examiner, physician, physician assistant, or nurse practitioner determines 
the chain of events that led to the patient’s death and other conditions that contributed to 
death and records them on the death certificate. EDRS includes the following three sections: 
(1) text fields for the causes of death; (2) associated International Classification of Diseases, 
Tenth Revision (ICD-10) codes; and (3) the underlying cause of death ICD-10 code as 
determined by algorithms performed by the National Center for Health Statistics.12 For our 
study, an EDRS coccidioidomycosis-attributable death was defined as any cause-of-death 
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text field including “cocci” or “Valley fever,” or including a coccidioidomycosis ICD-10 
record axis code (B38.0–B38.9). After review, we excluded deaths with cause-of-death text 
fields not related to coccidioidomycosis, including gram positive cocci, enterococci, and 
pneumococci.
Arizona’s HDD includes discharge records for all hospitals licensed by the Arizona 
Department of Health Services (ADHS); excluded are Veteran’s Administration hospitals, 
Department of Defense hospitals, and hospitals on tribal land. Discharge diagnoses were 
coded according to the International Classification of Diseases, Ninth Revision (ICD-9). For 
our study, an HDD coccidioidomycosis-attributable death was defined as a patient who died 
in the hospital; had an ICD-9 discharge diagnosis code for coccidioidomycosis (114.0–
114.9); had a death certificate (to confirm patient was actually deceased); and had laboratory 
confirmation of coccidioidomycosis in MEDSIS. For both databases, we restricted the 
analysis to deaths during 2008–2013 among Arizona residents.
Capture-Recapture
Capture-recapture is a method used to estimate the total number of a population by using 
multiple sources13 and is often selected in public health to estimate the total incidence of a 
disease, including unreported cases, by using multiple incomplete surveillance data sources.
14–17
 We used a 2-source capture-recapture method by using EDRS and HDD to estimate the 
total number of coccidioidomycosis-attributable deaths in Arizona during 2008–2013.
We matched cases of coccidioidomycosis-attributable deaths in EDRS and HDD by using 
Link Plus 2.0 software18 by name, social security number, and date of birth. The software 
assigns a score to each potential pair of patients based on the probability of a true match. 
Lower scores with a lower probability were reviewed for final determination of a match. 
Patients who were identified in HDD but were missing from EDRS (e.g., had a death 
certificate that did not include coccidioidomycosis as a cause of death) were identified.
Total number of coccidioidomycosis-attributable deaths was estimated by the Chapman 2-
source capture-recapture formula n = [(NEDRS+1)(NHDD+1)/(NBOTH+1)] − 1, where NEDRS 
= the number of deaths reported only in EDRS, NHDD = number of deaths reported only in 
HDD, and NBOTH = number of deaths reported in both databases;13,19 95% confidence 
intervals (CIs) were also determined.20,21 We calculated the sensitivity of 
coccidioidomycosis-attributable death estimates by using only EDRS and only HDD by 
comparing the number of coccidioidomycosis-attributable deaths reported from these 
sources with the capture-recapture estimate. We also calculated the sensitivity of 
coccidioidomycosis-attributable death estimates compared to the capture-recapture estimate 
using more narrow inclusion criteria, including only the underlying cause of death in EDRS, 
all ICD-10 cause of death codes on the death certificate not including text in EDRS, or only 
the primary diagnosis in HDD.
Case-Control
To determine risk factors for omitting coccidioidomycosis as a cause of death on the death 
certificate, we compared coccidioidomycosis-attributable deaths from HDD for which 
coccidioidomycosis was included as any cause of death (n = 251), including the text on the 
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death certificate, with those for which coccidioidomycosis was not included as cause of 
death on the death certificate (n = 309) during 2008–2013. We compared demographics, 
disseminated versus pulmonary disease, and comorbidities by using discharge ICD-9 codes 
for disease classification. Disseminated disease includes patients with ICD-9 codes for 
coccidioidomycosis meningitis (114.2) and progressive coccidioidomycosis (114.3). Patients 
with ICD-9 codes for chronic coccidioidomycosis (114.4), unspecified pulmonary 
coccidioidomycosis (114.5), and unspecified coccidioidomycosis (114.9) were not included 
when comparing disseminated and pulmonary disease. Immunocompromised status and 
malignancy were classified according to the Agency for Healthcare Research and Quality 
definitions.22 Unadjusted odds ratios (ORs) and CIs were calculated; we calculated adjusted 
odds ratios (aORs) by using a multivariable logistic regression model that included age, race, 
and sex, in addition to variables with significant unadjusted ORs (human immunodeficiency 
virus [HIV] status and type of coccidioidomycosis). All analyses used SAS® Version 9.3 
(SAS Institute, Incorporated, Cary, North Carolina, USA).
Medical record review and validation
To ensure that coccidioidomycosis contributed to the deaths identified in HDD for which 
coccidioidomycosis was not included as a cause of death on the death certificate (i.e., missed 
coccidioidomycosis-attributable deaths), medical records for all missed coccidioidomycosis-
attributable deaths that occurred in Maricopa County residents in 2012 were reviewed. 
Maricopa County was chosen because it accounted for ~65% of hospital deaths during 
2008–2013 (unpublished data, HDD, 2015). Two independent reviewers (epidemiologists 
trained in death certification and coccidioidomycosis) initially determined if 
coccidioidomycosis contributed to the death. Coccidioidomycosis was considered to have 
contributed to the patient’s death if it was listed in the death summary as a diagnosis, active 
coccidioidomycosis disease was described in the physician’s notes and appeared to 
contribute to death, and/or active disease was suggested by laboratory diagnosis and 
plausibly contributed to death (e.g., patient had a positive enzyme immunoassay (EIA) 
immunoglobulin (Ig) M and immunodiffusion tube precipitin and died of sepsis). A single 
positive EIA IgM in MEDSIS was considered insufficient for confirmation based on reports 
of false-positive results in the literature.23 Any discrepant results were reviewed by an 
infectious disease specialist trained in death certification for final determination. After 
excluding HDD deaths for which coccidioidomycosis could not be confirmed as a cause of 
death, we recalculated a capture-recapture estimate and compared this with the number of 
coccidioidomycosis-attributable deaths in EDRS and the HDD for deaths that occurred in 
Maricopa County residents during 2012.
Nonresearch determination was obtained since this was a public health response. For this 
type of study formal consent is not required. This article does not contain any studies with 
animals performed by any of the authors.
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During 2008–2013, a total of 529 coccidioidomycosis-attributable deaths were recorded in 
EDRS. Among these, 164 (31%) had coccidioidomycosis coded as the underlying cause of 
death; 333 (63%) had a coccidioidomycosis ICD-10 code, but coccidioidomycosis was not 
listed as the underlying cause of death; and 32 (6%) had cocci or Valley fever in the text 
cause-of-death field but without a coccidioidomycosis ICD-10 code.
During 2008–2013, HDD included 651 patient deaths with a discharge diagnosis 
coccidioidomycosis ICD-9 code. Of these, 251 (39%) were also in EDRS. Of the 400 HDD 
deaths not in EDRS, 399 (100%) had an associated death certificate (to confirm death) that 
did not list coccidioidomycosis as a cause of death, and one had no death certificate. 
Laboratory confirmation of coccidioidomycosis in MEDSIS was identified for 309 (77%) of 
these 399 unique HDD deaths.
We identified 278 deaths in EDRS that were not in the HDD, and 309 deaths in the HDD 
that were not in EDRS. By using capture-recapture, we estimated 1,178 (95% CI: 1100–
1256) total coccidioidomycosis-attributable deaths during 2008–2013 in Arizona (Fig. 1).
The sensitivities of EDRS coccidioidomycosis-attributable death estimates varied by 
inclusion criteria. Compared with the capture-recapture estimate, the EDRS estimate using 
all causes of death and including text had a sensitivity of 45% (95% CI: 42%–48%) or a 2.2-
fold underestimation (95% CI: 2.1–2.4). When the EDRS estimate using only the ICD-10 
codes without including text was compared with the capture-recapture estimate, EDRS had a 
sensitivity of 42% (95% CI: 40%–45%) or a 2.4-fold underestimation (95% CI 2.2–2.5). 
Lastly, the EDRS estimate including only the single underlying cause of death ICD-10 code 
had a sensitivity of 14% (95% CI: 13%–15%) or a 7.2-fold underestimation (95% CI: 6.7–
7.7), compared with the capture-recapture estimate (Table 1).
Case-Control
Patients identified in HDD with a death certificate that lists coccidioidomycosis as a cause of 
death were more likely to have a positive HIV test result (aOR: 2.4; 95% CI: 1.1–2.4) or 
have coccidioidomycosis meningitis or disseminated coccidioidomycosis (versus pulmonary 
coccidioidomycosis) (aOR: 1.7; 95% CI: 1.1–1.7), compared with patients in HDD with a 
death certificate that did not list coccidioidomycosis as a cause of death. Sex, race/ethnicity, 
diabetes, malignancy, immunocompromised status, and chronic obstructive pulmonary 
disease were not significantly associated with coccidioidomycosis being listed as a cause of 
death on the death certificate. Although not significant, decedents of younger age were more 
likely to have coccidioidomycosis listed as a cause of death on their death certificate (Table 
2).
Medical record review and validation
We identified 33 potential coccidioidomycosis-attributable deaths in Maricopa County 
residents during 2012 from HDD by reviewing death certificates that did not list 
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coccidioidomycosis as a cause of death. After medical records review, 24 (73%) were 
confirmed as coccidioidomycosis-attributable deaths; of these 24 deaths, 11 (46%) had 
coccidioidomycosis listed as a diagnosis on the death summary; 12 (50%) had physician 
notes or laboratory results confirming active coccidioidomycosis disease; and one (4%) had 
multiple positive laboratory tests for coccidioidomycosis in MEDSIS within 6 months of the 
patient’s death. On the 24 death certificates confirmed to be coccidioidomycosis-attributable 
deaths, 96 different causes of death were listed; the most common causes of death and 
associated ICD-10 codes were respiratory failure, un-specified (J96.9) (6 %), cardiac arrest, 
cause unspecified (I46.9) (5%), and atherosclerotic heart disease of native coronary artery 
(I25.1) (5%). Nine (27%) of the 33 deaths could not be confirmed as coccidioidomycosis-
attributable deaths relying on available medical records; when reviewing MEDSIS records 
within six months of the patient’s death, seven had only one positive EIA IgM, and two had 
no laboratory confirmation.
After restricting the analysis to coccidioidomycosis-attributable deaths in Maricopa County 
residents in 2012 reported in EDRS or verified by review of the medical records, we found 
30 deaths in both databases, 36 in EDRS alone, and 24 in the HDD alone (Fig. 2). By using 
capture-recapture, we estimated a total of 117 (95% CI: 97–137) coccidioidomycosis-
attributable deaths. Compared with the capture-recapture estimation, EDRS using all causes 
of death including text had a sensitivity of 56% (66/117; 95% CI: 48–68%) or a 1.8-fold 
underestimation (95% CI: 1.5–2.1). EDRS including only the ICD-10 codes without using 
text had a sensitivity of 51% (60/117; 95% CI: 44–62%) or a 2.0-fold underestimation (95% 
CI: 1.5–2.1). Finally, EDRS using only the single underlying cause of death ICD-10 code 
had a sensitivity of 13% (15/117; 95% CI: 11–15%) or a 7.8-fold underestimation (95% CI: 
6.5–9.1) (Table 1).
Discussion
By using the capture-recapture methodology, we estimated that 1,178 total 
coccidioidomycosis-attributable deaths occurred during 2008–2013 in Arizona. Methods of 
measuring the coccidioidomycosis mortality rate by using death certificate data 
underestimate the mortality burden from two- to sevenfold. For example, ADHS uses the 
underlying or secondary cause of death ICD-10 codes from death certificates in their Valley 
Fever Annual Report,24 resulting in an approximate twofold underestimate of the mortality 
burden. A national coccidioidomycosis mortality study also used this method.7 The method 
used by the ADHS Bureau of Public Health Statistics,25 which reports the 
coccidioidomycosis mortality rate only based on underlying cause of death ICD-10 code, 
underestimates the total burden approximately sevenfold.
Because HDD is an administrative database and the accuracy depends on the skill of coders, 
we took multiple steps to ensure that coccidioidomycosis actually contributed to the death of 
patients identified in this database. Even when restricting our analysis to deaths included in 
HDD with either a death certificate listing coccidioidomycosis as a cause of death or an 
available medical record that confirmed coccidioidomycosis as contributing to death, death 
certificates underestimated mortality at approximately the same amount (1.8-fold with 
medical record validation versus 2.2-fold without medical record validation). This study 
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reveals that when performing capture-recapture to estimate total coccidioidomycosis 
mortality by using EDRS and HDD, medical record validation (the most resource-intensive 
step of this study) might be unnecessary to calculate an accurate estimate.
Death certificate data assist in monitoring health trends, determining public health goals, and 
prioritizing which medical conditions receive research funding.26 However, cause of death 
information is frequently inaccurate or incomplete.8–11 Although this is the first study to 
document this problem for coccidioidomycosis, multiple studies have reported similar 
results when evaluating cause of death accuracy concerning death certificate data for other 
diseases, including cancer,27,28 heart disease,29 and drug overdose.30 Concerns have been 
raised that methodologies of tabulating death certificate data underestimate the mortality 
burden of infectious diseases.31 Multiple studies have reported heart disease to be 
overreported as a cause of death.32–35 The inaccuracies of death certificate data might be 
attributable to a lack of formal training in death certification of healthcare providers.11,35,36 
Additional training of medical residents has been demonstrated to be effective in improving 
the accuracy of death certification.11,35,37
In this study, patients diagnosed with HIV or disseminated coccidioidomycosis were more 
likely to have coccidioidomycosis included as a cause of death on the death certificate. HIV 
is a well-established risk factor for disseminated coccidioidomycosis38 and is known to 
increase the risk of dying because of the disease.2 Disseminated disease is also recognized as 
an AIDS-defining condition. Death certifiers are likely more aware of the risk for disease 
among persons who are HIV-positive in endemic regions and might be more likely to 
include coccidioidomycosis as a cause of death on the death certificate of a person infected 
with HIV.
Multiple limitations are notable, including the following three assumptions made when 
conducting capture-recapture analyses. First, sources should be independent of each other 
and dependence of sources leads to underestimation.13 EDRS and HDD likely have a level 
of dependence because patients who die in the hospital are likely to have a death certificate; 
therefore, our capture-recapture estimate is likely an underestimate. Second, deaths should 
have equal probability of being ascertained by each source and differences in ascertainment 
probabilities can lead to overestimation.13 The probability of ascertainment among sources 
in this study might differ because every death should have a death certificate, whereas only 
persons who died in a hospital licensed by ADHS are included in HDD; this could inflate 
our capture-recapture calculation. Third, the population should be closed to the outside; 
migration of persons in or out of population can lead to an overestimate.13 An estimated 5% 
of Arizona’s population resides in the state only during the winter months,39 but winter 
residents would not affect our study because we only included residents of Arizona; Arizona 
residents who died in out-of-state hospitals would not have been included in the HDD but 
should have been included in EDRS. This might also have inflated our capture-recapture 
calculation. We did not adjust our calculations for these limitations, which is consistent with 
other published public health capture-recapture analyses.15,16 Fourth, medical record 
validation was performed on a subset of deaths and the results might not represent the 
general study population. Lastly, the possibility exists that coccidioidomycosis did actually 
contribute to the cause of death for a portion of the 27% of patients whose medical records 
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lacked confirmation of coccidioidomycosis as a contributing cause of death, but the 
information was not included among available medical records. This can also lead to an 
underestimate of missed deaths.
In summary, estimates of coccidioidomycosis-attributable deaths that are based solely on 
death certificate data likely underestimate the true burden by at least twofold. Because 
unreliable death certificate data limit accurate mortality estimates for diseases of public 
health importance, medical education policy makers should consider incorporating death 
certification training into medical school and residency curricula and medical board 
certification requirements. ADHS offers online continuing medical education regarding 
death certification to all providers; however, this training is not mandatory. Public health 
agencies in coccidioidomycosis endemic areas should consider using HDD in addition to 
death certificate data to more accurately estimate coccidioidomycosis mortality. More 
accurate coccidioidomycosis mortality estimates might assist policy makers with prioritizing 
resources to support research regarding treatment and prevention of coccidioidomycosis to 
lessen the public health effects of the disease.
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Table 1
Number of coccidioidomycosis-attributable deaths and sensitivity of these methods compared with capture-
recapture estimation by measurement method and by site and year.
Measurement method
Arizona 2008–2013
Maricopa County 2012 with medical record 
validation1












estimation % (95% 
CI)
Death Certificates
 Underlying cause of death alone 164 14 (13–15) 15 13 (11–15)
All cause of death ICD-10 codes 497 42 (40–45) 60 51 (42–62)
 All cause of death ICD-10 codes and text 
fields2
529 45 (42–48) 66 56 (48–68)
Hospital discharge data3
 Primary diagnosis code only 101 9 (8–9) Not examined -
 All discharge codes 560 47 (45–51) 54 46 (39–56)
Capture-recapture estimate of total by 
using both death certificate and hospital 
discharge data4
1178 (1100–1256) ref 118 (98–138) ref
CI, confidence interval; ICD-10, International Classification of Diseases, Tenth Revision.
1
Medical records were reviewed for deaths recorded by hospital discharge data and coccidioidomycosis was not listed as a cause of death on the 
death certificate; deaths for which coccidioidomycosis could not be confirmed as a cause of death were excluded.
2Any cause of death text field including “cocci” or “valley fever” followed by review to ensure accuracy.
3
Hospital discharge data was defined as a patient who died at the hospital; had an ICD-9 discharge diagnosis code for coccidioidomycosis (114.0–
114.9); had a death certificate that did not record coccidioidomycosis as a cause of death; and had laboratory confirmation of coccidioidomycosis in 
MEDSIS.
4
Estimated by the formula n = [(NEDRS+1)(NHDD+1)/(NBOTH+1)] − 1, where NEDRS = the number of deaths only found in the EDRS, 
NHDD = the number of deaths only found in the hospital discharge data, and NBOTH = the number of deaths found in both databases.





















Jones et al. Page 14
Table 2
Factors associated with having coccidioidomycosis included as cause of death on death certificate among 
patients who died in hospital with discharge diagnosis of coccidioidomycosis—Arizona, 2008–2013.
Factor
Coccidioidomycosis listed as cause of death
Yes (n = 251) No (n = 309) Unadjusted OR Adjusted OR1
No. (%) No. (%) OR (95% CI) OR (95% CI)
Race/ethnicity
 Native American 12 (5) 23 (7) 0.7 (0.3–1.4) 0.6 (0.3–1.3)
 Black 20 (8) 25 (8) 1.0 (0.5–1.9) 0.7 (0.4–1.4)
 Hispanic 51 (20) 41 (13) 1.6 (1.0–2.5) 1.3 (0.8–2.1)
 White 160 (64) 204 (66) ref ref
 Other 8 (3) 16 (5) 0.6 (0.3–1.5) 0.7 (0.3–1.6)
Age (years)
 <25 14 (6) 6 (2) 2.7 (1.0–7.3) 2.5 (0.9–6.9)
 25–64 123 (49) 143 (47) ref ref
 65–84 102 (41) 135 (44) 0.9 (0.6–1.2) 1.1 (0.8–1.7)
 >85 12 (5) 25 (8) 0.6 (0.3–1.2) 0.6 (0.3–1.4)
 Female 92 (37) 114 (37) 1.0 (0.7–1.4) 1.3 (0.9–1.9)
 HIV-positive2 31 (12) 14 (5) 3.0 (1.5–5.7) 2.4 (1.1–5.0)4
 Immunocompromised2,3 130 (52) 149 (48) 1.2 (0.8–1.6) . . .
 Malignancy2,3 42 (17) 74 (24) 0.6 (0.4–1.0) . . .
 COPD2 55 (22) 88 (28) 0.7 (0.5–1.0) . . .
 Diabetes2 70 (28) 95 (31) 0.9 (0.6–1.3) . . .
Types of coccidioidomycosis
 Pulmonary 171 (68) 221 (72) ref ref
 Disseminated or meningitis 68 (27) 41 (13) 2.1 (1.4–3.3) 1.7 (1.1–2.8)
 Chronic 6 (2) 14 (5) 0.6 (0.2–1.5) 0.5 (0.2–1.4)
 Unspecified; 6 (2) 33 (11) 0.2 (0.1–0.6) 0.2 (0.1–0.5)
Bold font style indicates significance with P < .05. aOR, adjusted odds ratio; 95% CI, 95% confidence interval; COPD, chronic obstructive 
pulmonary syndrome; HIV, human immunodeficiency virus; OR, odds ratio.
1Adjusted for race/ethnicity, age, sex, HIV status, and type of coccidioidomycosis.
2
Presence of qualifying discharge diagnosis International Classification of Diseases, 9th Revision (ICD-9) code compared to no presence of 
qualifying ICD-9 code.
3Classified according to the Agency for Healthcare Research and Quality definitions (20).
4Adjusted for race/ethnicity, age, sex, and type of coccidioidomycosis but not for HIV.
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